ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DDSS Labopharm Inc. (MM)

0.14
0.00 (0.00%)
31 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Labopharm Inc. (MM) NASDAQ:DDSS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.14 0 01:00:00

LABOPHARM TO HOST CONFERENCE CALL WEDNESDAY, MAY 4, 2011 AT 8:30 A.M. (ET)

29/04/2011 5:00pm

PR Newswire (Canada)


Labopharm Inc. (MM) (NASDAQ:DDSS)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Labopharm Inc. (MM) Charts.
LAVAL, QC, April 29 /CNW/ -- - Management to discuss first quarter 2011 financial results - LAVAL, QC, April 29 /CNW/ - Labopharm Inc. (TSX: DDS); (NASDAQ: DDSS) today announced that it will host a conference call on Wednesday, May 4, 2011 at 8:30 a.m. (ET) to discuss its first quarter 2011 financial results. Labopharm will report its first quarter 2011 financial results via news release at approximately 7:00 a.m. (ET) the same day. To access the conference call by telephone, dial 647-427-7450 or 1-888-231-8191. Please connect approximately 15 minutes prior to the beginning of the call to ensure participation. The conference call will be archived for replay until Wednesday, May 11, 2011 at midnight. To access the archived conference call, dial 416-849-0833 or 1-800-642-1687 and enter the reservation number 62117516. A live audio webcast of the conference call will be available at www.labopharm.com. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. The webcast will be archived at the above web site for 30 days. About Labopharm Inc. Labopharm is focused on realizing value from its portfolio of commercialized products and creating additional value by leveraging its emerging technology platforms to develop increasingly differentiated products. For more information, visit www.labopharm.com. At The Equicom Group: Lawrence Chamberlain, Media and Investor Relations, Tel: (416) 815-0700 ext. 257, lchamberlain@equicomgroup.com; French: Joe Racanelli, Tel: (514) 844-7997, jracanelli@equicomgroup.com

Copyright

1 Year Labopharm Inc. (MM) Chart

1 Year Labopharm Inc. (MM) Chart

1 Month Labopharm Inc. (MM) Chart

1 Month Labopharm Inc. (MM) Chart

Your Recent History

Delayed Upgrade Clock